1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Endocrine Disruption Screening Market – By Assay Type

1.3.2        North America Endocrine Disruption Screening Market – By Application

1.3.3        North America Endocrine Disruption Screening Market – By Sources of waste

1.3.4        North America Endocrine Disruption Screening Market – By Method

1.3.5        North America Endocrine Disruption Screening Market – By End User

1.3.6        North America Endocrine Disruption Screening Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Endocrine Disruption Screening Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Endocrine Disruption Screening Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Endocrine Disorders

5.1.2        Surging Cases of Diabetes

5.2         Market Restraints

5.2.1        Screening Technology Being Expensive

5.3         Future Trends

5.3.1        Endocrine Disrupting Through Regulatory Approaches

5.4         Impact Analysis

6.           Endocrine Disruption Screening Market– North America Analysis

6.1         North America Endocrine Disruption Screening Market Revenue Forecast and Analysis

6.2         North America Endocrine Disruption Screening Market, By Country- Forecast and Analysis

7.           North America Endocrine Disruption Screening Market Revenue and Forecasts To 2028–  by Assay Type

7.1         Overview

7.2         North America Endocrine Disruption Screening Market, By Assay Type, 2021 & 2028 (%)

7.3         In-Virto

7.3.1        Overview

7.3.2        In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

7.4         In-Vivo

7.4.1        Overview

7.4.2        In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

8.           North America Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         North America Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)

8.3         Natural Materials

8.3.1        Overview

8.3.2        Natural Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

8.4         Synthetic Materials

8.4.1        Overview

8.4.2        Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.           North America Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Sources of Waste

9.1         Overview

9.2         North America Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)

9.3         Incineration and landfill

9.3.1        Overview

9.3.2        Incineration and landfill: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.4         Agricultural runoff

9.4.1        Overview

9.4.2        Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.5         Industrial and Municipal Effluents

9.5.1        Overview

9.5.2        Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.6         Pulp Mill Effluents

9.6.1        Overview

9.6.2        Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.7         Consumer Products

9.7.1        Overview

9.7.2        Consumer Products: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.8         Others

9.8.1        Overview

9.8.2        Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.        North America Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Method

10.1      Overview

10.2      North America Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)

10.3      Estrogen Receptor (ER) Transactivation

10.3.1     Overview

10.3.2     Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.4      Androgen Receptor (AR) Transactivation

10.4.1     Overview

10.4.2     Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.5      Androgen Receptor (AR) Modulation

10.5.1     Overview

10.5.2     Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.6      Estrogen Receptor-Alpha (ER-alpha) Binding

10.6.1     Overview

10.6.2     Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.7      Estrogen Receptor beta (ER-beta) Binding

10.7.1     Overview

10.7.2     Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.8      Androgen Receptor (AR) Binding

10.8.1     Overview

10.8.2     Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.9      Steroidogenesis

10.9.1     Overview

10.9.2     Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.10   Aromatase Assay

10.10.1  Overview

10.10.2  Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.11   Others

10.11.1  Overview

10.11.2  Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.        North America Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – End Use

11.1      Overview

11.2      North America Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)

11.3      Pharmaceutical and Biopharmaceutical Companies

11.3.1     Overview

11.3.2     Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028  (US$ Thousand)

11.4      Cosmetics and Household Product Companies

11.4.1     Overview

11.4.2     Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.5      Food Industry

11.5.1     Overview

11.5.2     Food Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.6      Chemical Industry

11.6.1     Overview

11.6.2     Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

12.        North America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 – Country Analysis

12.1      North America: Endocrine Disruption Screening Market

12.1.1     Overview

12.1.2     North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

12.1.2.1       US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.1.1       Overview

12.1.2.1.2       US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.1.3       US: Endocrine Disruption Screening Market, by Assay Type, 2019–2028 (US$ Thousands)

12.1.2.1.4       US: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousands)

12.1.2.1.5       US: Endocrine Disruption Screening Market, by Sources of waste, 2019–2028 (US$ Thousands)

12.1.2.1.6       US: Endocrine Disruption Screening Market, by Method, 2019–2028 (US$ Thousands)

12.1.2.1.7       US: Endocrine Disruption Screening Market, by End-user, 2019–2028 (US$ Thousands)

12.1.2.2       Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.2.1       Overview

12.1.2.2.2       Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.2.3       Canada: Endocrine Disruption Screening Market, by Assay Type, 2019–2028 (US$ Thousands)

12.1.2.2.4       Canada: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousands)

12.1.2.2.5       Canada: Endocrine Disruption Screening Market, by Sources of waste, 2019–2028 (US$ Thousands)

12.1.2.2.6       Canada: Endocrine Disruption Screening Market, by Method, 2019–2028 (US$ Thousands)

12.1.2.2.7       Canada: Endocrine Disruption Screening Market, by End-user, 2019–2028 (US$ Thousands)

12.1.2.3       Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.3.1       Overview

12.1.2.3.2       Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.2.3.3       Mexico: Endocrine Disruption Screening Market, by Assay Type, 2019–2028 (US$ Thousands)

12.1.2.3.4       Mexico: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousands)

12.1.2.3.5       Mexico: Endocrine Disruption Screening Market, by Sources of waste, 2019–2028 (US$ Thousands)

12.1.2.3.6       Mexico: Endocrine Disruption Screening Market, by Method, 2019–2028 (US$ Thousands)

12.1.2.3.7       Mexico: Endocrine Disruption Screening Market, by End-user, 2019–2028 (US$ Thousands)

13.        Impact Of COVID-19 Pandemic on North America Endocrine Disruption Screening Market

13.1      North America: Impact Assessment of COVID-19 Pandemic

14.        Endocrine Disruption Screening Market–Industry Landscape

14.1      Overview

14.2      Growth Strategies Done by the Companies in the Market (%)

14.3      Organic Developments

14.3.1     Overview

14.4      Inorganic Developments

14.4.1     Overview

15.        Company Profiles

15.1      CREATIVE BIOARRAY

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      CHARLES RIVER LABORATORIES, INC.

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Eurofins Scientific Ltd.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      SGS SA

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      SMITHERS

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      JRF Global

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Mérieux NutriSciences

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      aALPHA ANALYTICAL, Inc.

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 2.             US Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 3.             US Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 4.             US Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 5.             US Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 6.             Canada: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 7.             Canada Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 8.             Canada Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 9.             Canada Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 10.          Canada Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 11.          Mexico: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 12.          Mexico Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 13.          Mexico Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 14.          Mexico Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 15.          Mexico Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 16.          organic Developments Done by Companies

Table 17.          Inorganic Developments Done by Companies

Table 18.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Endocrine Disruption Screening Market Segmentation

Figure 2.           North America Endocrine Disruption Screening Market, By Country

Figure 3.           North America Endocrine Disruption Screening Market Overview

Figure 4.           In-Vitro Segment Held Largest Share of Assay Type Segment in North America Endocrine Disruption Screening Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to North America Endocrine Disruption Screening Market

Figure 9.           North America Endocrine Disruption Screening Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 10.        North America Endocrine Disruption Screening Market, by Assay Type, 2021 & 2028 (%)

Figure 11.        North America In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 12.        North America In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 13.        North America Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)

Figure 14.        North America Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 15.        North America Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 16.        North America Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)

Figure 17.        North America Incineration and landfill: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 18.        North America Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 19.        North America Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 20.        North America Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 21.        North America Consumer Products: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 22.        North America Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 23.        North America Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)

Figure 24.        North America Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 25.        North America Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 26.        North America Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 27.        North America Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 28.        North America Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 29.        North America Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028  (US$ Thousand)

Figure 30.        North America Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 31.        North America Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 32.        North America Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 33.        North America Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)

Figure 34.        North America Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 35.        North America Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 36.        North America Food Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 37.        North America Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 38.        North America: Endocrine Disruption Screening Market, by Key Country – Revenue (2021) (US$ Thousands)

Figure 39.        North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

Figure 40.        US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 41.        Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 42.        Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 43.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 44.        Growth Strategies Done by the Companies in the Market (%)